Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 May;34(5):1008-1026.
doi: 10.1002/ptr.6585. Epub 2020 Jan 6.

Herb-drug interaction studies of herbs used in treatment of cardiovascular disorders-A narrative review of preclinical and clinical studies

Affiliations
Review

Herb-drug interaction studies of herbs used in treatment of cardiovascular disorders-A narrative review of preclinical and clinical studies

Aaftab S Shaikh et al. Phytother Res. 2020 May.

Abstract

About 70% of the world population is currently using medicinal herbs as complementary or alternative medicine, which is increasing at a tremendous pace in both developed and developing countries in the last two decades (World Health Organization Medicines Strategy 2002-2005). This increase in consumer demand of medicinal herbs continues despite the rarity of scientific data to establish their safety and efficacy profile. Its popularity is also attributed to several factors, including easy availability, cost effectiveness leading to better purchasing power and general perception that they are safe. Herbs are often administered concomitantly with therapeutic drugs for the treatment of major ailments, raising the potential for herb-drug interactions (HDIs). The major pathways postulated for HDIs involves the cytochrome P450 (CYP450)-mediated inhibition or induction and transport and efflux proteins. In our review, we highlight frequently used herbal medicines for the treatment of cardiovascular disorders (CVD), their established HDIs studied using in vitro tools and in vivo pharmacokinetic and pharmacodynamic assays and case reports. Herbs have been divided into different sections on the basis of availability of HDI data in relevance to cardiovascular drugs: herbs reported to interact with cardiac drugs, herbs yet to be reported for interaction with drugs of any class and herbs reported to interact with drugs of other therapeutic category but not with cardiac drugs. The amount of active phytoconstituents present in the selected herbs and their extent of bioavailability are also mentioned. This review can serve as a quick reference database for physicians and health care professionals involved in CVD treatment, aimed at maximizing clinical outcomes with reduction in adverse and toxic effects.

Keywords: CYP inhibition; cardiovascular diseases; cardiovascular drugs; cardiovascular herbs; herb-drug interaction; herbs.

PubMed Disclaimer

Similar articles

Cited by

References

REFERENCES

    1. AARP and National Center for Complementary and Alternative Medicine. (2011). Complementary and alternative medicine: What people aged 50 and older discuss with their healthcare providers. Consumer Survery Report, (April), 1-14.
    1. Ahmmed, S. K. M., Mukherjee, P. K., Bahadur, S., Kar, A., Al-Dhabi, N. A., & Duraipandiyan, V. (2015). Inhibition potential of Moringa oleifera Lam on drug metabolizing enzymes. Indian Journal of Traditional Knowledge, 14(4), 614-619.
    1. Al-Ali, M., Wahbi, S., Twaij, H., & Al-Badr, A. (2003). Tribulus terrestris: Preliminary study of its diuretic and contractile effects and comparison with Zea mays. Journal of Ethnopharmacology, 85(2-3), 257-260.
    1. Amacher, D. E. (2010). The effects of cytochrome P450 induction by xenobiotics on endobiotic metabolism in pre-clinical safety studies. Toxicology Mechanisms and Methods, 20, 159-166.
    1. Andallu, B., & B. (2012). Hypoglycmic, diuretic and hypocholesterolemic effect of winter cherry (Withania somnifera, Dunal) root. Indian Journal of Experimental Biology, 3, 607-609.

MeSH terms

LinkOut - more resources